Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemLife is a Malaysia-based private stem cell banking and healthcare services company focused on umbilical cord blood, cord tissue, and related cryopreservation services. Founded in 2001, it was an early pioneer of private cord blood banking in Malaysia and now operates as a majority-owned subsidiary of Cordlife Group. In addition to collection, processing, storage, and release of stem cell units, the company offers logistics support and a suite of diagnostic services including non-invasive prenatal testing and newborn metabolic screening. StemLife is licensed under Malaysia's Private Healthcare Facilities and Services Act and has promoted quality credentials including AABB accreditation. Its business is primarily service-based rather than a drug-development biotech pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StemLife.